Conference News

MIDDLETOWN, Conn.--(BUSINESS WIRE)--PursueCare, a virtual clinic for substance use disorder (SUD) treatment, will participate in a panel exploring partnerships and strategies for integrated, whole-person care models in behavioral health at the 2025 Behavioral Health Business (BHB) Addiction Treatment Forum in Chicago, Ill., on July 17, 2025, at Convene (311 W Monroe). The forum also spotlights current investment and operational trends shaping the addiction treatment industry. Nicholas Mercadant...

STUTTGART, Germany--(BUSINESS WIRE)--Taicang received the prestigious “Zero-Carbon City” Best Practice Award, further solidifying its reputation as a benchmark for green transformation....

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Gilead researchers and collaborators will present new Phase 3 PURPOSE trial data at IAS 2025 showing that twice-yearly lenacapavir (Yeztugo®) was effective and well tolerated among a broad range of populations who need or want pre-exposure prophylaxis (PrEP) for HIV prevention, including pregnant and lactating women, adolescents and young people, and supports lenacapavir dosing recommendations for pe...

CONCORD, Mass.--(BUSINESS WIRE)--Aviva Bio, a new biotech start up, is developing d3-T, a non aromatizing testosterone, a safer, first in class T, the first to be approved for women....

NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced that the novel findings from its research, “Using large language models for scalable extraction of real-world progression events across multiple cancer types,” have been presented at the American Association for Cancer Research (AACR) Special Conference in Cancer Research: Artificial Intelligence and Machine Learning, which took place July 10-12, 2025, in Montreal, QC, Canada. The research, led by a multidisciplinary Flatiron team of cl...

LONDON, Ontario--(BUSINESS WIRE)--TennoCon, the annual celebration of all things Warframe and Soulframe, is happening this weekend with activities at RBC Place, The DoubleTree by Hilton, and Canada Life Place. 2025 marks the 10th year the record-breaking celebration has been conducted in Digital Extremes’ hometown, London, Ontario. Whether fans are attending the sold-out show in-person, joining online via livestream, or in-game, everyone is invited to TennoCon’s milestone year with a varied arr...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it has been named a 2025 Breakthroughs Innovation Celebration winner by Premier, Inc., a leading health care improvement company. The honor recognizes JOURNAVX™ (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor for the treatment of adults with moderate-to-severe acute pain, as a groundbreaking health care technology. “We are honored to be recognized at Premier’s 2025...

STAMFORD, Conn.--(BUSINESS WIRE)--Gartner, Inc. (NYSE: IT) What: Gartner IT Symposium/Xpo 2025 When: October 20-23, 2025 Where: Walt Disney World Resort, Orlando, Florida Details: Gartner IT Symposium/Xpo 2025 is the world's most important gathering of CIOs and other IT executives. More than 8,000 CIOs and senior leaders will explore the technology, insights and trends shaping the future of IT and business, including generative AI, business transformation, cybersecurity, customer experience, da...

WESTBOROUGH, Mass.--(BUSINESS WIRE)--Miach Orthopaedics’ presents real-world evidence on BEAR Implant highlighting one- and two-year results from the Bridge Registry study at AOSSM 2025....

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, today announced the presentation of preclinical data on MAR002, a novel growth hormone receptor (GHR) antagonist antibody for the treatment of acromegaly, at the 2025 Annual Meeting of the Endocrine Society (ENDO). The oral presentation, titled “Developmen...